| 中文名稱 | (2R,3S,5S)-3-芐氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-芐氧基-9H-嘌呤-9-基]-2-芐氧基甲基環(huán)戊醇 |
|---|
| 中文同義詞 | (2R,3S,5S)-3-芐氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-芐氧基-9H-嘌呤-9-基]-2-芐氧;(1S,2S,3S,5S)-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-(苯基甲氧基)-9H-嘌呤-9-基]-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]環(huán)戊醇;(2R,3S,5S)-3-芐氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-芐氧基-9H-嘌呤-9-基]-2-芐氧基甲基環(huán)戊醇;恩替卡韋中間體N5;恩替卡韋中間體五;(2R,3S,5S)-3-芐氧基;恩替卡韋-5;(2R,3S,5S)-3-(芐氧基)-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-(苯基甲氧基)-9H-嘌呤-9- |
|---|
| 英文名稱 | (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol |
|---|
| 英文同義詞 | (2R,3S,5S)-3-(Benzyloxy)-5-(6-benzyloxy)-2-(4-methyoxyphenyl)diphenylmethylamino)-9H-purin-9-yl)-2-benzyloxymethyl)cyclopentanol;(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol;(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-;(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol ,99%;[1S-(1α,2β,3α,5β)]-5-[2-[[(4-Methoxyphenyl)-diphenylMethyl]aMino]-6-(phenylMethoxy)-9H- purin-9-yl]-3-(phenylMethoxy)-2-[(phenyl-Methoxy)Methyl]cyclopentanol;Entecavir InterMediate V;(1S,2S,3S,5S)-5-(2-((4-Methoxyphenyl)diphenylMethylaMino)-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)Methyl)cyclopentanol;(1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-Methoxyphenyl)diphenylMethyl)aMino)-9H-purin-9-yl)-2-((benzyloxy)Methyl)cyclopentanol |
|---|
| CAS號(hào) | 142217-78-5 |
|---|
| 分子式 | C52H49N5O5 |
|---|
| 分子量 | 823.98 |
|---|
| EINECS號(hào) | 1308068-626-2 |
|---|
| 相關(guān)類別 | 醫(yī)藥中間體;醫(yī)藥原料;抗病毒;對(duì)照品-雜質(zhì)對(duì)照品;中間體 |
|---|
| Mol文件 | 142217-78-5.mol |
|---|
| 結(jié)構(gòu)式 | ![(2R,3S,5S)-3-芐氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-芐氧基-9H-嘌呤-9-基]-2-芐氧基甲基環(huán)戊醇 結(jié)構(gòu)式](CAS/GIF/142217-78-5.gif) |
|---|
